Anna R. Giuliano
YOU?
Author Swipe
View article: Supplementary Data from The Association between Smoking and Anal Human Papillomavirus in the HPV Infection in Men Study
Supplementary Data from The Association between Smoking and Anal Human Papillomavirus in the HPV Infection in Men Study Open
Supplementary Data from The Association between Smoking and Anal Human Papillomavirus in the HPV Infection in Men Study
View article: Data from The Association between Smoking and Anal Human Papillomavirus in the HPV Infection in Men Study
Data from The Association between Smoking and Anal Human Papillomavirus in the HPV Infection in Men Study Open
Background:Previous studies show an association between smoking and anal cancer. The objective of this study was to assess the association between smoking and anal HPV (human papillomavirus) prevalence, incidence, and persistence in men.Me…
View article: Effect of Prior 9-Valent Human Papillomavirus Vaccination on Subsequent Lower Genital Tract Dysplasia After Cervical Excisional Surgery
Effect of Prior 9-Valent Human Papillomavirus Vaccination on Subsequent Lower Genital Tract Dysplasia After Cervical Excisional Surgery Open
OBJECTIVE: To assess the efficacy of prior 9-valent human papillomavirus (9vHPV) vaccination on risk of subsequent cervical, vaginal, and vulvar disease after a cervical excisional procedure for cervical squamous intraepithelial lesion (SI…
View article: Anal Human Papillomavirus Infection Progression to Disease Among Men Who Have Sex With Men
Anal Human Papillomavirus Infection Progression to Disease Among Men Who Have Sex With Men Open
Background Critical gaps exist in our understanding of the progression from anal human papillomavirus (HPV) infection to same-type HPV-associated anal disease in HIV-negative men who have sex with men (MSM). We conduced a post hoc analysis…
View article: Persistence and clearance of oral human papillomavirus among a multi-national cohort of men
Persistence and clearance of oral human papillomavirus among a multi-national cohort of men Open
In response to the growing burden of HPV-associated oropharyngeal cancer, this study investigated clearance of oral HPV, the obligate precursor, in a longitudinal cohort of men from the US, Brazil, and Mexico. Oral gargles collected every …
View article: Supplementary Figure 3 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy
Supplementary Figure 3 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy Open
Supplemental Figure 3: Week 4 Plasma Cell-Free HPV (cfHPV) or Oral Gargle HPV DNA and its Association with Progression-free Survival (PFS). A) Comparison of PFS for patients with versus without week 4 plasma cfHPV DNA clearance. B) Compari…
View article: Figure 2 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy
Figure 2 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy Open
Dynamic changes of plasma cfHPV DNA and its association with reduction of TTV at week 4. A, Plasma cfHPV DNA kinetics before, during, and after definitive radiation treatment. Each colored line represents a patient. Colors of lines …
View article: Data from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy
Data from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy Open
Dynamic biomarkers that guide de-escalation strategies in human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC) remain an unmet need. In this study, we evaluated the kinetics of plasma cell-free HPV (cfHPV) DNA a…
View article: Figure 3 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy
Figure 3 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy Open
Association between baseline cfHPV DNA and PFS. Comparison of PFS for patients with low (
View article: Supplementary Table S1 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy
Supplementary Table S1 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy Open
Supplementary Table S1
View article: Table 1 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy
Table 1 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy Open
Baseline patient characteristics
View article: Supplementary Figure 4 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy
Supplementary Figure 4 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy Open
Supplemental Figure 4: Oral Gargle HPV DNA Collected at Weekly Intervals from Weeks 1 to 4 and Their Associations with Reduction of Target Tumor Volume (TTV) at Week 4. A) Comparison of the reduction of TTV at week 4 in patients with versu…
View article: Supplementary Figure 1 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy
Supplementary Figure 1 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy Open
Supplemental Figure 1: Trial Schema and Timepoints of Sample Collection. Oral gargle samples were collected at weekly intervals from baseline to week 4, then at end of treatment and at 3, 6, and 12 months after treatment. Plasma samples we…
View article: Supplementary Figure 2 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy
Supplementary Figure 2 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy Open
Supplemental Figure 2: Association of Baseline Clinical Characteristics with Plasma and Oral Gargle HPV DNA Status. Bar charts show the comparison of proportions of patients with A) detectable versus undetectable baseline plasma cfHPV DNA …
View article: Figure 1 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy
Figure 1 from Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy Open
Waterfall plot showing the % change of week 4 TTV compared with baseline for all patients who met the inclusion criteria (N = 50). Each legend at the bottom of the waterfall plot show the status of HPV DNA clearance for oral gargle …
View article: Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy
Plasma Cell-Free Human Papillomavirus DNA and Oral Gargle HPV DNA in Patients with HPV-Related Oropharyngeal Cancer Treated with Radiotherapy Open
Dynamic biomarkers that guide de-escalation strategies in human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC) remain an unmet need. In this study, we evaluated the kinetics of plasma cell-free HPV (cfHPV) DNA a…
View article: Oral human papillomavirus (HPV) prevalence and genotyping among healthy adult populations in the United States and Europe: results from the PROGRESS (PRevalence of Oral hpv infection, a Global aSSessment) study
Oral human papillomavirus (HPV) prevalence and genotyping among healthy adult populations in the United States and Europe: results from the PROGRESS (PRevalence of Oral hpv infection, a Global aSSessment) study Open
[This corrects the article DOI: 10.1016/j.eclinm.2024.103018.].
View article: Neutralizing antibody response to SARS-CoV-2 variants, as determined by the MSD multiplex assay, following COVID-19 vaccination in cancer patients
Neutralizing antibody response to SARS-CoV-2 variants, as determined by the MSD multiplex assay, following COVID-19 vaccination in cancer patients Open
Background: Immunocompromised populations, especially cancer patients, rely on the effectiveness of the COVID-19 vaccines to protect against severe infection or death, both against the original wild-type (WT) SARS CoV-2 virus and its many …
View article: The Association Between Alcohol Consumption and Anal Human Papillomavirus in the HPV Infection in Men Study
The Association Between Alcohol Consumption and Anal Human Papillomavirus in the HPV Infection in Men Study Open
Background Human papillomavirus (HPV) can lead to anal cancer in men and women. The aim of this analysis was to assess the association between alcohol consumption and the prevalence and incidence of anal HPV among 1,919 men. Methods The HP…
View article: Shifting HPV-cancer burden: from cervical cancer to oropharyngeal cancer
Shifting HPV-cancer burden: from cervical cancer to oropharyngeal cancer Open
Addressing the rising OPC trend requires a multifaceted approach, including gender-neutral HPV vaccination, the development of OPC screening methods, and increased public awareness. Sustained efforts in HPV-related cancer prevention are cr…
View article: Immunogenicity of the 9-valent human papillomavirus vaccine: Post hoc analysis from five phase 3 studies
Immunogenicity of the 9-valent human papillomavirus vaccine: Post hoc analysis from five phase 3 studies Open
Post hoc analyses of 9-valent human papillomavirus (9vHPV) vaccine immunogenicity were conducted in five Phase 3 studies that enrolled males. Month 7 antibody geometric mean titers (GMTs) after three 9vHPV vaccine doses were analyzed in 10…
View article: Oral human papillomavirus (HPV) prevalence and genotyping among healthy adult populations in the United States and Europe: results from the PROGRESS (PRevalence of Oral hpv infection, a Global aSSessment) study
Oral human papillomavirus (HPV) prevalence and genotyping among healthy adult populations in the United States and Europe: results from the PROGRESS (PRevalence of Oral hpv infection, a Global aSSessment) study Open
View article: Natural history of HPV-16 E6 serology among cancer-free men in a multicenter longitudinal cohort study
Natural history of HPV-16 E6 serology among cancer-free men in a multicenter longitudinal cohort study Open
Background Human papillomavirus (HPV) type 16 E6 protein seropositivity accurately predicts oropharyngeal squamous cell carcinoma risk decades before diagnosis; but the biomarker’s translational potential is unknown. To inform consideratio…
View article: Multinational epidemiological analysis of oral human papillomavirus incidence in 3,137 men
Multinational epidemiological analysis of oral human papillomavirus incidence in 3,137 men Open
View article: Human papillomavirus‐driven head and neck cancers in Japan during 2008–2009 and 2018–2019: The BROADEN study
Human papillomavirus‐driven head and neck cancers in Japan during 2008–2009 and 2018–2019: The BROADEN study Open
There is limited understanding of epidemiology and time trends of human papilloma virus (HPV)‐driven head and neck cancers (HNC) in Japan, especially outside of the oropharynx. To assess HPV‐driven HNC, a non‐interventional study (BROADEN)…
View article: Anal human papillomavirus (HPV) disagreement by Linear Array compared to SPF10 PCR-DEIA-LiPA25 system in young sexual minority men
Anal human papillomavirus (HPV) disagreement by Linear Array compared to SPF10 PCR-DEIA-LiPA25 system in young sexual minority men Open
Our results highlight the importance of HPV detection methods which may inform different interpretations of research assessing anal HPV natural history among SMM at highest risk for HPV.
View article: The influence of home versus clinic anal human papillomavirus sampling on high-resolution anoscopy uptake in the Prevent Anal Cancer Self-Swab Study
The influence of home versus clinic anal human papillomavirus sampling on high-resolution anoscopy uptake in the Prevent Anal Cancer Self-Swab Study Open
Background Anal cancer disproportionately affects sexual and gender minority individuals living with HIV. High-resolution anoscopy (HRA) is an in-clinic procedure to detect precancerous anal lesions and cancer, yet prospective data on fact…
View article: Engagement and factors associated with annual anal human papillomavirus screening among sexual and gender minority individuals
Engagement and factors associated with annual anal human papillomavirus screening among sexual and gender minority individuals Open
Objectives Annual screening with a provider has been recommended for groups at highest risk for anal cancer. Anal self-sampling could help address screening barriers, yet no studies have examined annual engagement with this method. Methods…
View article: A cross-sectional study of the association of dental health factors with progression and all-cause mortality in men diagnosed with HPV-associated oropharyngeal cancer
A cross-sectional study of the association of dental health factors with progression and all-cause mortality in men diagnosed with HPV-associated oropharyngeal cancer Open
Background Human Papillomavirus-associated oropharyngeal cancer (HPV-OPC) incidence is increasing among men in the United States. Poor dental health has previously been associated with risk of head and neck cancers, oral HPV infection, and…
View article: Data from Identification of a Biomarker Panel from Genome-Wide Methylation to Detect Early HPV-Associated Oropharyngeal Cancer
Data from Identification of a Biomarker Panel from Genome-Wide Methylation to Detect Early HPV-Associated Oropharyngeal Cancer Open
As oropharyngeal cancer (OPC) associated with human papillomavirus (HPV) increases in men, the need for a screening test to diagnose OPC early is crucial. This study agnostically identified differentially methylated CpG sites to identify a…